Confluent Medical Invests in The Electrospinning Company

May 4, 2021

Confluent Medical Technologies made a strategic minority investment in The Electrospinning Company Ltd to access its proprietary electrospinning process and expand design/manufacturing options for the transcatheter structural heart market. The investment aims to combine Confluent's Nitinol and biomedical textile expertise with Electrospinning's nanofiber biomaterials capability and to automate the application of textiles to valve frames.

Buyers
Confluent Medical Technologies Inc.
Targets
The Electrospinning Company Ltd.
Industry
Medical Devices
Location
England, United Kingdom
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.